SKIN BARRIER SUN SHIELD SPF 30

SKIN BARRIER SUN SHIELD SPF 30 was reported 141 times

These side effects are most commonly reported by patients taking SKIN BARRIER SUN SHIELD SPF 30:

# Side effect Count
0 RASH 14
1 ACNE 10
2 ERYTHEMA 9
3 SUNBURN 9
4 DRY SKIN 8
5 MALIGNANT MELANOMA 8
6 HEADACHE 7
7 OFF LABEL USE 7
8 APPLICATION SITE ERYTHEMA 6
9 DERMATITIS 6
10 PAIN 6
11 PHOTOSENSITIVITY REACTION 6
12 SWELLING FACE 6
13 ARTHRALGIA 5
14 BLISTER 5
15 CONDITION AGGRAVATED 5
16 DEPRESSION 5
17 DIARRHOEA 5
18 DRUG INEFFECTIVE 5
19 FATIGUE 5
20 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5
21 PRODUCT USE ISSUE 5
22 PRURITUS 5
23 PSORIASIS 5
24 SKIN EXFOLIATION 5
25 XEROSIS 5
26 APPLICATION SITE PAIN 4
27 BASAL CELL CARCINOMA 4
28 DRUG HYPERSENSITIVITY 4
29 DRY EYE 4
30 ECZEMA 4
31 HYPERSENSITIVITY 4
32 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
33 MALAISE 4
34 PAIN OF SKIN 4
35 SKIN BURNING SENSATION 4
36 SOMNOLENCE 4
37 THERAPEUTIC RESPONSE UNEXPECTED 4
38 ANXIETY 3
39 ASTHENIA 3
40 BURNING SENSATION 3
41 CHEILITIS 3
42 COUGH 3
43 HEART RATE INCREASED 3
44 HOSPITALISATION 3
45 ILLNESS 3
46 INTENTIONAL PRODUCT MISUSE 3
47 MOOD ALTERED 3
48 NAUSEA 3
49 PIGMENTATION DISORDER 3
50 RASH ERYTHEMATOUS 3
51 SENSITIVE SKIN 3
52 SKIN DISCOLOURATION 3
53 SKIN HYPERPIGMENTATION 3
54 SKIN IRRITATION 3
55 UNDERDOSE 3
56 URTICARIA 3
57 WEIGHT DECREASED 3
58 ABDOMINAL DISCOMFORT 2
59 ABDOMINAL PAIN UPPER 2
60 ABNORMAL LOSS OF WEIGHT 2
61 ACNE CYSTIC 2
62 ADVERSE EVENT 2
63 APPLICATION SITE DISCHARGE 2
64 APPLICATION SITE DISCOLOURATION 2
65 APPLICATION SITE EXFOLIATION 2
66 BACK PAIN 2
67 CHOLECYSTITIS ACUTE 2
68 CHOLESTASIS 2
69 CONTUSION 2
70 DEATH 2
71 DECREASED APPETITE 2
72 DRUG INTOLERANCE 2
73 DRY MOUTH 2
74 DYSPHAGIA 2
75 DYSPNOEA 2
76 EYE IRRITATION 2
77 EYE PAIN 2
78 FALL 2
79 GASTROINTESTINAL HAEMORRHAGE 2
80 HYPERHIDROSIS 2
81 IMMUNE SYSTEM DISORDER 2
82 IMMUNE-MEDIATED HEPATITIS 2
83 INFECTION 2
84 INFLAMMATION 2
85 INTENTIONAL PRODUCT USE ISSUE 2
86 INTENTIONAL UNDERDOSE 2
87 JOINT SWELLING 2
88 LENTIGO 2
89 LUNG NEOPLASM MALIGNANT 2
90 MELANOCYTIC NAEVUS 2
91 MILIARIA 2
92 MIOSIS 2
93 MUSCLE SPASMS 2
94 MYALGIA 2
95 OVERDOSE 2
96 PAIN IN EXTREMITY 2
97 PERIPHERAL SWELLING 2
98 PNEUMONIA 2
99 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
100 PRODUCT DOSE OMISSION ISSUE 2
101 PRODUCT QUALITY ISSUE 2
102 PSORIATIC ARTHROPATHY 2
103 PYREXIA 2
104 RASH MACULAR 2
105 RASH PAPULAR 2
106 SEBORRHOEIC KERATOSIS 2
107 SEIZURE 2
108 SKIN HAEMORRHAGE 2
109 SKIN LESION 2
110 SKIN WARM 2
111 SQUAMOUS CELL CARCINOMA 2
112 SWELLING 2
113 TACHYCARDIA 2
114 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
115 ABDOMINAL DISTENSION 1
116 ABDOMINAL PAIN 1
117 ACCIDENTAL EXPOSURE TO PRODUCT 1
118 ACTINIC KERATOSIS 1
119 ACUTE KIDNEY INJURY 1
120 ACUTE PULMONARY OEDEMA 1
121 ADDISON^S DISEASE 1
122 ALANINE AMINOTRANSFERASE INCREASED 1
123 ALOPECIA 1
124 AMMONIA INCREASED 1
125 ANAEMIA 1
126 ANAL FISTULA 1
127 ANGIOPATHY 1
128 APPLICATION SITE HAEMORRHAGE 1
129 APPLICATION SITE IRRITATION 1
130 APPLICATION SITE NODULE 1
131 APPLICATION SITE PRURITUS 1
132 APPLICATION SITE RASH 1
133 APPLICATION SITE SCAB 1
134 APPLICATION SITE SWELLING 1
135 APPLICATION SITE VESICLES 1
136 ARTHROPOD STING 1
137 ASCITES 1
138 ASPARTATE AMINOTRANSFERASE INCREASED 1
139 ASPIRATION 1
140 ASTHMA 1
141 ATRIAL FIBRILLATION 1
142 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1
143 BACK DISORDER 1
144 BACTERIAL INFECTION 1
145 BALANCE DISORDER 1
146 BLOOD CALCIUM INCREASED 1
147 BLOOD CHOLESTEROL INCREASED 1
148 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
149 BLOOD GLUCOSE INCREASED 1
150 BLOOD PRESSURE DECREASED 1
151 BLOOD PRESSURE INCREASED 1
152 BRONCHOSPASM 1
153 C-REACTIVE PROTEIN 1
154 CARDIAC MURMUR 1
155 CARDIOMEGALY 1
156 CATARACT OPERATION 1
157 CEREBROVASCULAR ACCIDENT 1
158 CHEMICAL BURN 1
159 CHEMICAL BURNS OF EYE 1
160 CHEST PAIN 1
161 CONFUSIONAL STATE 1
162 CONJUNCTIVITIS ALLERGIC 1
163 CONSTIPATION 1
164 CONTRAINDICATED PRODUCT ADMINISTERED 1
165 CONVULSION 1
166 COVID-19 1
167 DEHYDRATION 1
168 DERMATITIS CONTACT 1
169 DERMATITIS PSORIASIFORM 1
170 DIABETES MELLITUS 1
171 DISABILITY 1
172 DISCOMFORT 1
173 DISEASE PROGRESSION 1
174 DISEASE RECURRENCE 1
175 DROOLING 1
176 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
177 DRUG EFFECT INCOMPLETE 1
178 DRUG EFFECT LESS THAN EXPECTED 1
179 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
180 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
181 DYSPEPSIA 1
182 DYSPNOEA EXERTIONAL 1
183 ENCEPHALITIS 1
184 ENDOMETRIOSIS 1
185 EPISTAXIS 1
186 EXPIRED PRODUCT ADMINISTERED 1
187 EXPOSURE TO MOULD 1
188 EYE OEDEMA 1
189 FACIAL ASYMMETRY 1
190 FEELING HOT 1
191 FLATULENCE 1
192 FLUSHING 1
193 FREQUENT BOWEL MOVEMENTS 1
194 FUNGAL OESOPHAGITIS 1
195 GAIT DISTURBANCE 1
196 GASTRIC ULCER 1
197 GASTROENTERITIS VIRAL 1
198 GASTROINTESTINAL DISORDER 1
199 GASTROINTESTINAL MELANOSIS 1
200 GENERAL PHYSICAL HEALTH DETERIORATION 1
201 GLOSSODYNIA 1
202 GUTTATE PSORIASIS 1
203 HAEMANGIOMA 1
204 HAEMATURIA 1
205 HAEMORRHAGE 1
206 HAIR COLOUR CHANGES 1
207 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1
208 HEPATITIS 1
209 HOT FLUSH 1
210 HYPERAESTHESIA 1
211 HYPEREOSINOPHILIC SYNDROME 1
212 HYPERGLYCAEMIA 1
213 HYPERKERATOSIS 1
214 HYPERSOMNIA 1
215 HYPERTENSION 1
216 HYPERTRIGLYCERIDAEMIA 1
217 HYPOPHAGIA 1
218 HYPOTENSION 1
219 IMMUNOSUPPRESSION 1
220 INCORRECT DOSAGE ADMINISTERED 1
221 INCORRECT DRUG ADMINISTRATION DURATION 1
222 INCORRECT PRODUCT ADMINISTRATION DURATION 1
223 INCORRECT PRODUCT STORAGE 1
224 INFLUENZA LIKE ILLNESS 1
225 INJECTION SITE DRYNESS 1
226 INJECTION SITE HAEMORRHAGE 1
227 INJECTION SITE MASS 1
228 INJECTION SITE PAIN 1
229 INJECTION SITE PRURITUS 1
230 INJECTION SITE REACTION 1
231 INJECTION SITE SWELLING 1
232 INJURY ASSOCIATED WITH DEVICE 1
233 INSOMNIA 1
234 INTENTIONAL DOSE OMISSION 1
235 JAUNDICE 1
236 JOINT WARMTH 1
237 LIP DRY 1
238 LIVER FUNCTION TEST INCREASED 1
239 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
240 LOW DENSITY LIPOPROTEIN INCREASED 1
241 MALIGNANT MELANOMA IN SITU 1
242 MENINGITIS VIRAL 1
243 METASTATIC MALIGNANT MELANOMA 1
244 MIGRAINE 1
245 MOBILITY DECREASED 1
246 MOUTH ULCERATION 1
247 MUSCLE DISORDER 1
248 MUSCULAR WEAKNESS 1
249 MUSCULOSKELETAL DISCOMFORT 1
250 MUSCULOSKELETAL STIFFNESS 1
251 MYELOSUPPRESSION 1
252 NAIL DISORDER 1
253 NASAL CONGESTION 1
254 NASAL OEDEMA 1
255 NASOPHARYNGITIS 1
256 NEPHROLITHIASIS 1
257 NERVE INJURY 1
258 NEUTROPENIA 1
259 NODULE 1
260 OCULAR HYPERAEMIA 1
261 OCULAR ICTERUS 1
262 OEDEMA 1
263 OESOPHAGEAL ULCER 1
264 ORGANISING PNEUMONIA 1
265 OSTEOMYELITIS 1
266 OXYGEN SATURATION DECREASED 1
267 PALPITATIONS 1
268 PETECHIAE 1
269 PINGUECULA 1
270 PLASMA CELL MYELOMA 1
271 POOR QUALITY PRODUCT ADMINISTERED 1
272 PRE-EXISTING CONDITION IMPROVED 1
273 PRODUCT ADMINISTRATION INTERRUPTED 1
274 PRODUCT DOSE OMISSION 1
275 PRODUCT STORAGE ERROR 1
276 PRODUCT USE IN UNAPPROVED INDICATION 1
277 PRODUCTIVE COUGH 1
278 PSYCHOTIC DISORDER 1
279 PULMONARY EMBOLISM 1
280 PULMONARY HAEMORRHAGE 1
281 PYOGENIC GRANULOMA 1
282 RALES 1
283 RASH MACULO-PAPULAR 1
284 RASH PRURITIC 1
285 RECTAL HAEMORRHAGE 1
286 RED BLOOD CELL COUNT INCREASED 1
287 RESPIRATORY DISORDER 1
288 RESPIRATORY FAILURE 1
289 RETINAL HAEMORRHAGE 1
290 SCAB 1
291 SCAR 1
292 SCLERODERMA 1
293 SCRATCH 1
294 SEBORRHOEIC DERMATITIS 1
295 SELF-INJURIOUS IDEATION 1
296 SEPSIS 1
297 SKIN ATROPHY 1
298 SKIN CANCER 1
299 SKIN DEPIGMENTATION 1
300 SKIN DISCOMFORT 1
301 SKIN DISORDER 1
302 SKIN MASS 1
303 SKIN PLAQUE 1
304 SKIN REACTION 1
305 SKIN TIGHTNESS 1
306 SLEEP DISORDER 1
307 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
308 SOLAR DERMATITIS 1
309 SPINAL DISORDER 1
310 STOMATITIS 1
311 SUICIDAL IDEATION 1
312 SYSTEMIC LUPUS ERYTHEMATOSUS 1
313 TACHYPNOEA 1
314 THERAPEUTIC PRODUCT INEFFECTIVE 1
315 THIRST 1
316 TONGUE ULCERATION 1
317 TRIGGER FINGER 1
318 TYPE 2 DIABETES MELLITUS 1
319 UPPER RESPIRATORY TRACT INFECTION 1
320 URINARY INCONTINENCE 1
321 URINARY RETENTION 1
322 VASCULAR INJURY 1
323 VASCULITIS 1
324 VISION BLURRED 1
325 VITILIGO 1
326 VITREOUS HAEMORRHAGE 1
327 VOMITING 1
328 VON WILLEBRAND^S DISEASE 1
329 WALKING DISABILITY 1
330 WEIGHT INCREASED 1
331 WOUND 1